The Current Ratio as of November 2024 (TTM) for Paratek Pharmaceuticals, Inc. (PRTK) is 3.66

According to Paratek Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.66. This represents a change of 37.04% compared to the average of 2.67 of the last 4 quarters.

Paratek Pharmaceuticals, Inc. (PRTK) Historical Current Ratio (quarterly & annually)

How has PRTK Current Ratio performed in the past?

The mean historical Current Ratio of Paratek Pharmaceuticals, Inc. over the last ten years is 12.81. The current 3.66 Current Ratio has changed 2.76% with respect to the historical average. Over the past ten years (40 quarters), PRTK's Current Ratio was at its highest in in the December 2013 quarter at 38.19. The Current Ratio was at its lowest in in the June 2023 quarter at 0.52.

Paratek Pharmaceuticals, Inc. (PRTK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Paratek Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Paratek Pharmaceuticals, Inc. (PRTK) Average Current Ratio

How has PRTK Current Ratio performed in the past?

The current Current Ratio of Paratek Pharmaceuticals, Inc. (PRTK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Paratek Pharmaceuticals, Inc. (PRTK) Current Ratio vs. Peers

How is PRTK’s Current Ratio compared to its peers?

Paratek Pharmaceuticals, Inc.’s Current Ratio is greater than Selecta Biosciences, Inc. (1.33), greater than Corvus Pharmaceuticals, Inc. (0.92), less than Immutep Limited (18.25), less than Icosavax, Inc. (18.06), less than Lyra Therapeutics, Inc. (0), greater than Equillium, Inc. (3.64), greater than HOOKIPA Pharma Inc. (3.04), greater than LianBio (3.26), less than Jasper Therapeutics, Inc. (10.06), less than Affimed N.V. (7.61), greater than Leap Therapeutics, Inc. (1.93), less than Adaptimmune Therapeutics plc (3.97), less than Aptose Biosciences Inc. (3.85), greater than null (1.05),

Build a custom stock screener for Paratek Pharmaceuticals, Inc. (PRTK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Paratek Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Paratek Pharmaceuticals, Inc. (PRTK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Paratek Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.